References:
- Centers for Disease Control and Prevention. Managing tuberculosis patients and improving adherence. CDC, Atlanta, GA 2014.
- Burman WJ, Cohn DL, Rietmeijer CA, et al. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997; 111:1168.
- Moonan PK, Quitugua TN, Pogoda JM, et al. Does directly observed therapy (DOT) reduce drug resistant tuberculosis? BMC Public Health 2011; 11:19.
- Kim S, Crittenden K. Treatment completion among TB patients returned to the community from a large urban jail. J Community Health 2007; 32:135.
- Ehman M, Shaw T, Cass A, et al. Developing and using performance measures based on surveillance data for program improvement in tuberculosis control. J Public Health Manag Pract 2013; 19:E29.
- Mitruka K, Winston CA, Navin TR. Predictors of failure in timely tuberculosis treatment completion, United States. Int J Tuberc Lung Dis 2012; 16:1075.
Reproduced from: Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016; 63(7):e147-e195, by permission of Oxford University Press on behalf of the Infectious Diseases Society of America. Copyright © 2016 Oxford University Press. Available at:
www.idsociety.org.